CXCR4 Chemokine Receptor regulation of ERK MAP Kinase

CXCR4 趋化因子受体对 ERK MAP 激酶的调节

基本信息

  • 批准号:
    6640103
  • 负责人:
  • 金额:
    $ 28.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-09-30 至 2006-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by the applicant): T lymphocyte activation and migration are critical for normal immune functions, and signaling by the T lymphocyte antigen receptor-CD3 complex (TCR) and chemokine receptors such as CXCR4 are extensively cross regulated. For example, CXCR4 costimulates the immune activation of TCR-stimulated T lymphocytes, while TCR signaling abrogates CXCR4-mediated migration and participates in CXCR4-mediated infection of T lymphocytes with the Human Immunodeficiency Virus-1 (HIV-1). Despite evidence that TCR and CXCR4 signaling pathways cross-regulate in important ways, CXCR4 signaling pathways in T lymphocytes are incompletely characterized. Moreover, to our knowledge, no detailed studies on the molecular mechanisms of chemokine or CXCR4 and TCR cross-regulation have been reported. Our recent results demonstrate that CXCR4 signaling regulates a close association between CXCR4 and TCR on the surface of T lymphocytes, and activates the ERK MAP kinase via a mechanism requiring the TCR and TCR associated signaling molecules. Our proposed experiments will therefore fill this gap in the current knowledge, by testing the central hypothesis that CXCR4 signals in T cells via a novel mechanism that involves CXCR4 associating with the TCR and using the TCR for signal transduction. Our specific aims are to (1) ask if the interaction between CXCR4 and the TCR is specific, (2) ask how CXCR4 signaling regulates the CXCR4/TCR complex and its movement into subcellular compartments where signaling takes place, and (3) ask if CXCR4 uses the TCR and other signaling proteins for ERK activation and costimulation of TCR signaling. The results of these studies will characterize novel mechanisms of CXCR4 signaling in T cells that are important for CXCA4-mediated gene expression, and that probably also contribute to CXCR4-mediated costimulation of T cell activation and HIV-1 pathobiology. In addition, whether or not the CXCR4/TCR complex is eventually found to have biological relevance, these experiments will address basic questions of how receptors oligomerize, and signal from within, subcellular compartments. Finally, these experiments will identify reagents that can be used to rigorously test the idea that CXCR4/TCR complexes regulate T lymphocyte biological functions. The results of these studies will therefore serve as a theoretical framework for better understanding and manipulating the interplay between T cell immune activation and T cell migration.
描述(由申请人提供):T淋巴细胞的激活和迁移是正常免疫功能的关键,T淋巴细胞抗原受体-CD3复合体(TCR)和趋化因子受体(如CXCR4)的信号广泛交叉调节。例如,CXCR4共刺激TCR刺激的T淋巴细胞的免疫激活,而TCR信号则取消CXCR4介导的迁移,并参与CXCR4介导的T淋巴细胞感染人类免疫缺陷病毒1(HIV-1)。尽管有证据表明TCR和CXCR4信号通路在重要方面相互调节,但T淋巴细胞中的CXCR4信号通路尚不完全清楚。此外,据我们所知,关于趋化因子或CXCR4和TCR交叉调节的分子机制还没有详细的研究报道。我们最近的结果表明,CXCR4信号调节T淋巴细胞表面CXCR4和TCR之间的紧密结合,并通过一种需要TCR和TCR相关信号分子的机制激活ERK MAPK。因此,我们提出的实验将填补当前知识的这一空白,通过测试中心假设,即T细胞中的CXCR4信号通过一种新的机制,涉及CXCR4与TCR相关联,并使用TCR进行信号转导。我们的具体目的是(1)了解CXCR4和TCR之间的相互作用是否具有特异性;(2)CXCR4信号如何调节CXCR4/TCR复合体及其移动到信号发生的亚细胞室;(3)CXCR4是否使用TCR和其他信号蛋白来激活ERK和共刺激TCR信号。这些研究的结果将描述T细胞中CXCR4信号的新机制,这对CXCA4介导的基因表达是重要的,也可能有助于CXCR4介导的T细胞激活和HIV-1病理生物学的协同刺激。此外,无论最终是否发现CXCR4/TCR复合体具有生物学相关性,这些实验都将解决受体如何寡聚以及如何从亚细胞内发出信号的基本问题。最后,这些实验将确定可用于严格测试CXCR4/TCR复合体调节T淋巴细胞生物学功能的试剂。因此,这些研究的结果将为更好地理解和操纵T细胞免疫激活和T细胞迁移之间的相互作用提供理论框架。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAREN E. HEDIN其他文献

KAREN E. HEDIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAREN E. HEDIN', 18)}}的其他基金

Targeting osteoblasts to inhibit AML
靶向成骨细胞抑制 AML
  • 批准号:
    9058501
  • 财政年份:
    2015
  • 资助金额:
    $ 28.9万
  • 项目类别:
CXCR4 Chemokine Receptor regulation of ERK MAP Kinase
CXCR4 趋化因子受体对 ERK MAP 激酶的调节
  • 批准号:
    6796264
  • 财政年份:
    1999
  • 资助金额:
    $ 28.9万
  • 项目类别:
CXCR4 Chemokine Receptor Regulation of ERK MAP Kinase
CXCR4 趋化因子受体对 ERK MAP 激酶的调节
  • 批准号:
    8464135
  • 财政年份:
    1999
  • 资助金额:
    $ 28.9万
  • 项目类别:
CXCR4 CHEMOKINE RECEPTOR REGULATION OF ERK MAP KINASE
CXCR4 趋化因子受体对 ERK MAP 激酶的调节
  • 批准号:
    6386570
  • 财政年份:
    1999
  • 资助金额:
    $ 28.9万
  • 项目类别:
CXCR4 Chemokine Receptor regulation of ERK MAP Kinase
CXCR4 趋化因子受体对 ERK MAP 激酶的调节
  • 批准号:
    6942985
  • 财政年份:
    1999
  • 资助金额:
    $ 28.9万
  • 项目类别:
CXCR4 Chemokine Receptor regulation of ERK MAP Kinase
CXCR4 趋化因子受体对 ERK MAP 激酶的调节
  • 批准号:
    6542314
  • 财政年份:
    1999
  • 资助金额:
    $ 28.9万
  • 项目类别:
CXCR4 Chemokine Receptor Regulation of ERK MAP Kinase
CXCR4 趋化因子受体对 ERK MAP 激酶的调节
  • 批准号:
    8627608
  • 财政年份:
    1999
  • 资助金额:
    $ 28.9万
  • 项目类别:
CXCR4 Chemokine Receptor Regulation of ERK MAP Kinase
CXCR4 趋化因子受体对 ERK MAP 激酶的调节
  • 批准号:
    7575794
  • 财政年份:
    1999
  • 资助金额:
    $ 28.9万
  • 项目类别:
CXCR4 Chemokine Receptor Regulation of ERK MAP Kinase
CXCR4 趋化因子受体对 ERK MAP 激酶的调节
  • 批准号:
    8233798
  • 财政年份:
    1999
  • 资助金额:
    $ 28.9万
  • 项目类别:
CXCR4 Chemokine Receptor Regulation of ERK MAP Kinase
CXCR4 趋化因子受体对 ERK MAP 激酶的调节
  • 批准号:
    8813582
  • 财政年份:
    1999
  • 资助金额:
    $ 28.9万
  • 项目类别:

相似海外基金

The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
  • 批准号:
    DP240102905
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23K28188
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
  • 批准号:
    2339172
  • 财政年份:
    2024
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
  • 批准号:
    10577518
  • 财政年份:
    2023
  • 资助金额:
    $ 28.9万
  • 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23H03498
  • 财政年份:
    2023
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
  • 批准号:
    10676407
  • 财政年份:
    2023
  • 资助金额:
    $ 28.9万
  • 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
  • 批准号:
    22KK0277
  • 财政年份:
    2023
  • 资助金额:
    $ 28.9万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
  • 批准号:
    10599584
  • 财政年份:
    2023
  • 资助金额:
    $ 28.9万
  • 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
  • 批准号:
    10530023
  • 财政年份:
    2022
  • 资助金额:
    $ 28.9万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    $ 28.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了